FASEB J. Mp Biomedicals
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-122275.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Buy
Right arrow All Versions of this Article:
fj.08-122275v1
23/6/1893    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Díaz-Hernández, M.
Right arrow Articles by Lucas, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Díaz-Hernández, M.
Right arrow Articles by Lucas, J. J.
(The FASEB Journal. 2009;23:1893-1906.)
© 2009 FASEB

Altered P2X7-receptor level and function in mouse models of Huntington’s disease and therapeutic efficacy of antagonist administration

Miguel Díaz-Hernández*,{dagger},{ddagger},1, María Díez-Zaera{ddagger},1, Jesús Sánchez-Nogueiro*,{ddagger}, Rosa Gómez-Villafuertes{ddagger}, Josep M. Canals{dagger},§, Jordi Alberch{dagger},§, María Teresa Miras-Portugal{ddagger} and José J. Lucas*,{dagger},2

* Centro de Biología Molecular "Severo Ochoa", Consejo Superior de Investigaciònes Cientificas/Universidad Autonóma de Madrid, Madrid, Spain;

{dagger} Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas, Instituto de Salud Carlos III, Madrid, Spain;

{ddagger} Departamento de Bioquímica y Biología Molecular IV, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid, Spain; and

§ Departament de Biologia Cellular i Anatomia Patològica, Facultat de Medicina, Institut d’Investigacions Biomèdiques August Pi i Sunyer, Universitat de Barcelona, Barcelona, Spain

2Correspondence: Centro de Biología Molecular "Severo Ochoa", CSIC/UAM, Campus UAM de Cantoblanco, 28049 Madrid. Spain. E-mail: jjlucas{at}cbm.uam.es

The precise mechanism by which mutant huntingtin elicits its toxicity remains unknown. However, synaptic alterations and increased susceptibility to neuronal death are known contributors to Huntington’s disease (HD) symptomatology. While decreased metabolism has long been associated with HD, recent findings have surprisingly demonstrated reduced neuronal apoptosis in Caenorhabditis elegans and Drosophila models of HD by drugs that diminish ATP production. Interestingly, extracellular ATP has been recently reported to elicit neuronal death through stimulation of P2X7 receptors. These are ATP-gated cation channels known to modulate neurotransmitter release from neuronal presynaptic terminals and to regulate cytokine production and release from microglia. We hypothesized that alteration in P2X7-mediated calcium permeability may contribute to HD synaptic dysfunction and increased neuronal apoptosis. Using mouse and cellular models of HD, we demonstrate increased P2X7-receptor level and altered P2X7-mediated calcium permeability in somata and terminals of HD neurons. Furthermore, cultured neurons expressing mutant huntingtin showed increased susceptibility to apoptosis triggered by P2X7-receptor stimulation. Finally, in vivo administration of the P2X7-antagonist Brilliant Blue-G (BBG) to HD mice prevented neuronal apoptosis and attenuated body weight loss and motor-coordination deficits. These in vivo data strongly suggest that altered P2X7-receptor level and function contribute to HD pathogenesis and highlight the therapeutic potential of P2X7 receptor antagonists.—Díaz-Hernández, M., Díez-Zaera, M., Sánchez-Nogueiro, J., Gómez-Villafuertes, R., Canals, J. M., Alberch, J., Miras-Portugal, M. T., Lucas, J. J. Altered P2X7-receptor level and function in mouse models of Huntington’s disease and therapeutic efficacy of antagonist administration.


Key Words: ATP • calcium • apoptosis • polyglutamine • BBG




This article has been cited by other articles:


Home page
NeurologyHome page
E. E. Benarroch
Adenosine triphosphate: A multifaceted chemical signal in the nervous system
Neurology, February 16, 2010; 74(7): 601 - 607.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.